Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01810679 · ClinicalTrials.gov registry record · NA
Perceval S Aortic Heart Valve Study- North America
A NA study, sponsored by Sorin Group USA.
- Terminated
- Registry status
- NA
- Development phase
- 355
- Enrollment target
NCT01810679 is a NA study that was terminated before completion, run by Sorin Group USA. The registered enrollment target is 355 participants.
The verdict
NCT01810679, a NA study, was terminated before completion, sponsored by Sorin Group USA.
- TERMINATED
- Registry status
- NA
- Development phase
- 355 participants
- Enrollment target
Study Summary
To demonstrate the safety and effectiveness of the Perceval S heart valve when used to replace a diseased or dysfunctional aortic valve or aortic valve prosthesis.
Interventions
- DEVICE Perceval S Aortic Heart Valve
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 355 participants |
| Start Date | 2013-04 |
| Est. Completion | 2018-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01810679
The ClinicalTrials.gov registry entry for NCT01810679 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 355 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sorin Group USA, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Perceval S Aortic Heart Valve is the first listed.
NCT01810679 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01810679 about?
NCT01810679 is a clinical study titled "Perceval S Aortic Heart Valve Study- North America". To demonstrate the safety and effectiveness of the Perceval S heart valve when used to replace a diseased or dysfunctional aortic valve or aortic valve prosthesis.
What is the current status of trial NCT01810679?
This trial is currently terminated. It is a NA study. The enrollment target is 355 participants. The study started on 2013-04. Estimated completion is 2018-04.
What interventions are being tested in trial NCT01810679?
The interventions under investigation include: Perceval S Aortic Heart Valve (DEVICE).
Who is sponsoring clinical trial NCT01810679?
This trial is sponsored by Sorin Group USA, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.